GlassScriptPhysician profile
Kavitha Rajendran
NPI 1124538301
$1,392.97
in general payments reported to CMS, 2019-2025
14 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.27 · 2022: $374 · 2023: $309 · 2024: $156 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Travel and Lodging: $66.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.43 |
| Travel and Lodging | $66.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.92 | 2022-2025 | |
| Astellas Pharma US INC | $308.46 | 2021-2024 | Veozah |
| Boston Scientific Corporation | $302.52 | 2025 | Rezum Generator, Ams 700 |
| 180 Medical, INC. | $85.08 | 2022-2024 | |
| Pfizer INC. | $71.10 | 2021-2023 | |
| Hologic Sales and Service, LLC | $60.95 | 2022-2023 | Coolseal Generator, Acessa Provu System |
| Almirall LLC | $49.09 | 2022 | |
| Axonics, INC. | $41.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $25.37 | 2024 | Exparel |
| Myovant Sciences INC. | $25.33 | 2021 | |
| Convatec INC. | $22.50 | 2023 | |
| Sumitomo Pharma America, INC. | $20.41 | 2023 | Myfembree |
| Coopersurgical, INC. | $18.97 | 2023 | Paragard T 380a |
| Antares Pharma, INC. | $18.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kavitha Rajendran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.